NCT02527018View on ClinicalTrials.gov

A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

October 31, 2017

Conditions
PreeclampsiaMaternalHypertensionPregnancy
Interventions
DEVICE

Sphygmomanometer

Non-invasive reliable method of continuous measuring arterial blood pressure in pregnant women. Nextfin provides continuous blood pressure, heart rate, cardiac output, stroke volume, systemic vascular resistance and left ventricular contractility indices.

Trial Locations (1)

92868

University of California, Department of OBGYN, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT02527018 - A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women | Biotech Hunter | Biotech Hunter